CN1394655A - Preparation method of collagen/chitosan porous scaffold for tissue engineering - Google Patents
Preparation method of collagen/chitosan porous scaffold for tissue engineering Download PDFInfo
- Publication number
- CN1394655A CN1394655A CN 02112498 CN02112498A CN1394655A CN 1394655 A CN1394655 A CN 1394655A CN 02112498 CN02112498 CN 02112498 CN 02112498 A CN02112498 A CN 02112498A CN 1394655 A CN1394655 A CN 1394655A
- Authority
- CN
- China
- Prior art keywords
- collagen
- chitosan
- solution
- preparation
- tissue engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 104
- 102000008186 Collagen Human genes 0.000 title claims abstract description 100
- 108010035532 Collagen Proteins 0.000 title claims abstract description 100
- 229920001436 collagen Polymers 0.000 title claims abstract description 100
- 238000002360 preparation method Methods 0.000 title claims description 18
- -1 aldehyde compound Chemical class 0.000 claims abstract description 14
- 238000004132 cross linking Methods 0.000 claims abstract description 12
- 238000004108 freeze drying Methods 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 57
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 42
- 210000002435 tendon Anatomy 0.000 claims description 27
- 235000015278 beef Nutrition 0.000 claims description 26
- 238000007710 freezing Methods 0.000 claims description 14
- 230000008014 freezing Effects 0.000 claims description 14
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000010382 chemical cross-linking Methods 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 238000000053 physical method Methods 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 11
- 230000015556 catabolic process Effects 0.000 abstract description 9
- 238000006731 degradation reaction Methods 0.000 abstract description 9
- 238000001291 vacuum drying Methods 0.000 abstract description 5
- 239000012620 biological material Substances 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 7
- 240000007711 Peperomia pellucida Species 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 240000001439 Opuntia Species 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CHADEQDQBURGHL-UHFFFAOYSA-N (6'-acetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 CHADEQDQBURGHL-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a porous scaffold with controllable microstructure, proper degradation rate and good biological compatibility prepared by using natural biological materials of collagen and chitosan as raw material and adopting the processes of freeze-freeze drying, further vacuum drying and heating and cross-linking of aldehyde compound or carbodiimide compound. The biological compatibility of said invented collagen/chitosan scaffold is good, its degradation rate can be controlled, and its raw material source is extensive and its cost is low, and its reproducibility is good. Said scaffold can be extensively used in the field of tissue engineering technology.
Description
Technical field
The present invention relates to the preparation method of used in tissue engineering collagen/chitosan porous rack, relate to the preparation method of the histocompatibility three-dimensional porous rack that is used for transmitting tissue and neomorph specifically.
Background technology
Organizational project is one and relates to multidisciplinary, multi-field crossing research problems such as medical science, chemistry, biology, materialogy, and the structure of three-dimensional rack is one of key wherein.Only construct have specific microstructure, good mechanical performance, suitable degradation property and the support of excellent biological compatibility, could promote the adhesion and the growth of cell effectively, and then the regeneration of transmitting tissue and organ.
Collagen is the main component in the mammal connective tissue, constitutes the protein of human body about 30%, and the dry weight in skin reaches 72%.Collagen has 19 types, and modal is I type, II type and III type.Wherein the I type is the abundantest, and function admirable, is widely used in biomaterial.Though collagen-based materials has unrivaled biocompatibility, but the mechanical strength of the support that makes up with pure collagen is lower, degradation rate is too fast, can not satisfy the requirement of tissue engineering bracket, therefore it is also crosslinked with acquisition and the similar supporting structure of extracellular matrix by suitable method with the performance of improving collagen scaffold to be necessary to add other component, and has the degradation rate that is complementary with tissue regeneration.
Chitosan is a kind of polysaccharose substance that has polyamino, the main component glycosaminoglycan of its structure and some character and extracellular matrix is similar, have excellent biological compatibility and suitable degradation property, nonirritant, non-immunogenicity, no heat source response, and have the function that promotes wound healing, and wide material sources, with low cost.Chitosan has been widely used in suture, Wound dressing and the organizational project three-dimensional rack at present.
Summary of the invention
The preparation method that the purpose of this invention is to provide a kind of used in tissue engineering collagen/chitosan porous rack.
The present invention is to be material with collagen and chitosan, prepares the used in tissue engineering porous support by freezing-lyophilization, and adopts the method for physics and chemistry to carry out cross-linking modified to porous support.This preparation method may further comprise the steps:
1) respectively under acid condition compound concentration (by weight) be 0.1%～5%, be preferably 0.3%～3% collagen solution and chitosan solution, chitosan solution is splashed in the collagen solution, stir the collagen/chitosan mixed solution, the content of chitosan solution (by weight) is 1～80%, is preferably 5～30%;
2) the collagen/chitosan blended liquid is injected mould, adopts freezing-lyophilization, at-10 ℃～-100 ℃, be preferably under-10 ℃～-50 ℃ temperature after freezing 0.05～5 hour, lyophilizing in freeze dryer must the collagen/chitosan three-dimensional porous rack;
3) with step 2) gained collagen/chitosan three-dimensional porous rack is crosslinked with vacuum xeothermic physical method, crosslinking temperature is 80～130 ℃, time is 1～48 hour, soaked 1～3 hour at acetic acid solution then, put into aldehyde compound or the chemical crosslinking of carbodiimides compounds 1～48 hour again;
4) clean freezing once more, lyophilizing.
Among the present invention, the collagen-based materials of preparation collagen solution is beef tendon collagen, pigskin collagen, Mus tail collagen.Preparation collagen solution and the used acid of chitosan solution are a kind of or its mixture in acetic acid, formic acid, the hydrochloric acid.The pH value of said collagen/chitosan mixed liquor is 2～5.
Among the present invention, aldehyde compound is formaldehyde or glutaraldehyde.The concentration of aldehyde compound is 0.01%～2.5%, and preferred concentration is 0.05～0.25%.
Among the present invention, the carbodiimides compounds is meant 1-ethyl-3-3 dimethyl amine propyl group-carbodiimides (EDAC).The Carbodiimides compound concentrations is the aqueous solution of 0.001～1M, and preferred concentration is 0.01～0.3M.
Molecular weight to said chitosan material among the present invention does not have special requirement, is 1～2,000,000 chitosan but preferably use molecular weight ranges.
The material that the inventive method adopted belongs to natural biologic material, has excellent biological compatibility and degradability, and material source is extensive, and is with low cost.Adopt freezing-lyophilization can pass through the micro structure of the factor may command porous supports such as blend ratio of adjusting cryogenic temperature, blended liquid concentration or pH value, collagen and chitosan, prepare three-dimensional porous rack with suitable aperture and porosity.The employing chitosan is a bridging agent, and is crosslinked to regulate the degradation rate of porous support through the method for physics or chemistry.Be prepared into reconstruction or the regeneration that porous support can be widely used in multiple tissues such as skin, cartilage, bone, blood vessel, nerve, tendon, cardiac valve or organ by the present invention, with the external structure or the internal regeneration of above-mentioned tissue of effective promotion or organ.
Description of drawings
Fig. 1 a chitosan concentration is 10% o'clock, the SEM photo of support;
Fig. 1 b chitosan concentration is 50% o'clock, the SEM photo of support;
Fig. 2 a cryogenic temperature is the SEM photo of the support for preparing under-50 ℃ of conditions;
Fig. 2 b cryogenic temperature is the SEM photo of the support for preparing under-20 ℃ of conditions;
The chitosan concentration of the glutaraldehyde cross-linking of Fig. 3 variable concentrations is the degradation property of 10% beef tendon collagen/chitosan support;
The chitosan concentration of Fig. 4 0.25% glutaraldehyde cross-linking is 10% the laser confocal microscope photo of beef tendon collagen/chitosan support plantation 3T3 cell after 7 days;
The chitosan concentration of Fig. 5 a 0.25% glutaraldehyde cross-linking is 10% 3 days tissue slice figure of the beef tendon collagen/chitosan support implantation rabbit ear back of the body;
Fig. 5 b is that the chitosan concentration of 0.25% glutaraldehyde cross-linking is 10% 7 days tissue slice figure of the beef tendon collagen/chitosan support implantation rabbit ear back of the body;
Fig. 5 c is that the chitosan concentration of 0.25% glutaraldehyde cross-linking is 10% 14 days tissue slice figure of the beef tendon collagen/chitosan support implantation rabbit ear back of the body;
Fig. 5 d is that the chitosan concentration of 0.25% glutaraldehyde cross-linking is 10% 28 days tissue slice figure of the beef tendon collagen/chitosan support implantation rabbit ear back of the body;
Fig. 6 is that the chitosan concentration of 0.25% glutaraldehyde cross-linking is the pigskin collagen/laser confocal microscope photo of chitosan stent plantation 3T3 cell after 7 days of 10%;
The specific embodiment
Embodiment 1: chitosan content is to the influence of the micro structure of beef tendon collagen/chitosan porous rack
The method that adopts enzymolysis to combine with sour extracting is extracted from beef tendon and is obtained beef tendon collagen.With acetic acid solution respectively compound concentration be that 0.5% collagen solution and concentration are 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution are obtained the collagen/chitosan mixed solution that chitosan content is respectively (by weight) 10%, 20%, 30%, 50%.In-20 ℃ freezing 1 hour, can prepare porous support after the lyophilizing with different apertures and pattern, see Fig. 1 a, Fig. 1 b.Fig. 1 a, Fig. 1 b are respectively that chitosan content is scanning electron microscope (SEM) photo of 10%, 50% collagen/chitosan support.
Embodiment 2: cryogenic temperature is to the influence of the micro structure of beef tendon collagen/chitosan porous rack
The method that adopts enzymolysis to combine with sour extracting is extracted from beef tendon and is obtained beef tendon collagen.With the acetic acid solution of 0.5M respectively compound concentration be 0.5% collagen solution and 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution being obtained chitosan content is the collagen/chitosan mixed solution of (by weight) 10%.Then respectively at-50 ℃ ,-20 ℃ freezing 1 hour, can prepare the different porous support of pore size after the lyophilizing, see Fig. 2 a, Fig. 2 b.Fig. 2 a, Fig. 2 b are respectively at-50 ℃, the SEM photo of the porous support of cryopreparation under-20 ℃ of temperature.
Embodiment 3: beef tendon collagen/chitosan porous rack crosslinked
The method that adopts enzymolysis to combine with sour extracting is extracted from beef tendon and is obtained beef tendon collagen.With the acetic acid solution of 0.5M respectively compound concentration be that 0.5% collagen solution and concentration are 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution being obtained chitosan content is the collagen/chitosan mixed solution of (by weight) 10%.Adopt freezing-lyophilization, in-20 ℃ freezing 1 hour, lyophilizing in 24 hours in the freeze dryer then.Xeothermic crosslinked 24 hours of freeze dried collagen/chitosan support vacuum in 105 ℃ vacuum drying oven obtains xeothermic crosslinked beef tendon collagen/chitosan porous rack.Through the beef tendon collagen/chitosan porous rack of the xeothermic crosslinked acquisition of vacuum soaks 1 hour in the acetic acid solution of 100ml 0.5M after, in 4 ℃ crosslinked 24 hours down with 0.05%～0.25% glutaraldehyde solution, repeatedly after the rinsing, freezing once more-lyophilizing obtains the different collagen/chitosan porous rack of the degree of cross linking with tri-distilled water.The degradation resistant performance of crosslinked back beef tendon collagen/chitosan porous rack is significantly improved, and sees Fig. 3.
Embodiment 4: beef tendon collagen/chitosan porous rack in-vitro evaluation
The method that adopts enzymolysis to combine with sour extracting is extracted from beef tendon and is obtained beef tendon collagen.With the acetic acid solution of 0.5M respectively compound concentration be that 0.5% collagen solution and concentration are 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution being obtained chitosan content is the collagen/chitosan mixed solution of (by weight) 10%.Adopt freezing-lyophilization, in-20 ℃ freezing 1 hour, lyophilizing in 24 hours in the freeze dryer then.Xeothermic crosslinked 24 hours of freeze dried collagen/chitosan support vacuum in 105 ℃ vacuum drying oven.The xeothermic crosslinked porous support of vacuum soaked in the acetic acid solution of 100ml 0.5M after 1 hour, in 4 ℃ crosslinked 24 hours down with 0.25% glutaraldehyde solution, repeatedly after the rinsing, freezing once more-the crosslinked collagen/chitosan porous rack of lyophilizing acquisition with tri-distilled water.3T3 cell (5,000,000/ml), 37 ℃ of following 5%CO of plantation 1ml in this porous support
2Cultivated in the incubator 7 days, the next day change liquid.Fluorescein diacetate (FDA) dyeing back laser confocal microscope (CLSM) is observed under rack surface visible a large amount of 3T3 cells in the 200 μ m, and cell growth state is good, sees Fig. 4.
Embodiment 5: beef tendon collagen/chitosan porous rack interior evaluating
The method that adopts enzymolysis to combine with sour extracting is extracted from beef tendon and is obtained beef tendon collagen.With the acetic acid solution of 0.5M respectively compound concentration be that 0.5% collagen solution and concentration are 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution being obtained chitosan content is the collagen/chitosan mixed solution of (by weight) 10%.Adopt freezing-lyophilization, in-20 ℃ freezing 1 hour, lyophilizing in 24 hours in the freeze dryer then.Xeothermic crosslinked 24 hours of freeze dried collagen/chitosan support vacuum in 105 ℃ vacuum drying oven.The xeothermic crosslinked porous support of vacuum soaked in the acetic acid solution of 100ml 0.5M after 1 hour, in 4 ℃ crosslinked 24 hours down with 0.25% glutaraldehyde solution, repeatedly after the rinsing, freezing once more-the crosslinked collagen/chitosan porous rack of lyophilizing acquisition with tri-distilled water.Be imbedded at the full thick skin wound surface of rabbit of artificial excision after the support sterilization,, 7 days, 14 days, make tissue slice after 28 days and observe respectively at after the heeling-in 3 days.Heeling-in has a small amount of inflammatory cell to exist after 3 days.Visible fibroblast is grown into after 7 days, and supporting structure still keeps, and does not see tangible inflammatory cell in the support, after 14 days, had a large amount of fibroblastic growths to enter in the support, and support has had vascularization to a certain degree.Heeling-in has been merged intact in surrounding tissue after 28 days, be the dermal tissue sample, sees Fig. 5 a, Fig. 5 b, Fig. 5 c, Fig. 5 d.Fig. 5 a, Fig. 5 b, Fig. 5 c, Fig. 5 d are respectively the collagen/chitosan support and implanted 3 days, and 7 days, 14 days, 28 days tissue slice figure.
Embodiment 6: pigskin collagen/chitosan porous rack makes up and in-vitro evaluation
The method that adopts enzymolysis to combine with sour extracting is extracted from fresh porcine skin and is obtained pigskin collagen.With the acetic acid solution of 0.5M respectively compound concentration be that 0.5% collagen solution and concentration are 0.5% chitosan solution, then chitosan solution and the even blend of collagen solution being obtained chitosan content is the collagen/chitosan mixed solution of (by weight) 10%.Adopt freezing-lyophilization, in-20 ℃ freezing 1 hour, lyophilizing in 24 hours in the freeze dryer then.Xeothermic crosslinked 24 hours of freeze dried collagen/chitosan support vacuum in 105 ℃ vacuum drying oven, the xeothermic crosslinked porous support of vacuum soaks after 1 hour in the acetic acid solution of 100ml 0.5M, in 4 ℃ crosslinked 24 hours down with 0.25% glutaraldehyde solution, repeatedly after the rinsing, freezing once more-lyophilizing obtains crosslinked collagen/chitosan porous rack with tri-distilled water.3T3 cell (5,000,000/ml), 37 ℃ of following 5%CO of plantation 1ml in this porous support
2Cultivated in the incubator 7 days, the next day change liquid.FDA dyeing back CLSM observes on the visible hole wall in support and is pasted with a large amount of 3T3 cells, and cell is the rounded grain shape, and the as seen existing intercellular substance of iuntercellular exists, and sees Fig. 6.
Claims (10)
1. the preparation method of used in tissue engineering collagen/chitosan porous rack is characterized in that it may further comprise the steps:
1) respectively under acid condition compound concentration (by weight) be 0.1%～5% collagen solution and chitosan solution, chitosan solution is splashed in the collagen solution, stir the collagen/chitosan mixed solution, the content of chitosan solution (by weight) is 1～80%;
2) the collagen/chitosan blended liquid is injected mould, adopt freezing-lyophilization, after under-10 ℃～-100 ℃ temperature freezing 0.05～5 hour, lyophilizing in freeze dryer gets the collagen/chitosan three-dimensional porous rack;
3) with step 2) gained collagen/chitosan three-dimensional porous rack is crosslinked with vacuum xeothermic physical method, crosslinking temperature is 80～130 ℃, time is 1～48 hour, soaked 1～3 hour at acetic acid solution then, put into aldehyde compound or the chemical crosslinking of carbodiimides compounds 1～48 hour again;
4) clean freezing once more, lyophilizing.
2. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, the collagen-based materials that it is characterized in that preparing collagen solution is beef tendon collagen, pigskin collagen, Mus tail collagen.
3. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, it is characterized in that preparing collagen solution and the used acid of chitosan solution and be a kind of or its mixture in acetic acid, formic acid, the hydrochloric acid.
4. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, it is characterized in that said collagen/chitosan mixed liquor, the content of its chitosan solution (by weight) is 5～30%.
5. press the preparation method of claims 1 described used in tissue engineering collagen/chitosan porous rack, the pH value that it is characterized in that said collagen/chitosan mixed liquor is 2～5.
6. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, it is characterized in that said aldehyde compound is formaldehyde or glutaraldehyde.
7. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, it is characterized in that the carbodiimides compounds is meant 1-ethyl-3-3 dimethyl amine propyl group-carbodiimides.
8. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, it is characterized in that step 2) cryogenic temperature be-10 ℃～-50 ℃.
9. by the preparation method of the described used in tissue engineering collagen/chitosan porous rack of claim 1, the concentration that it is characterized in that said aldehyde compound is 0.01%～2.5%, and preferred concentration is 0.05～0.25%.
10. press the preparation method of claims 1 described used in tissue engineering collagen/chitosan porous rack, it is characterized in that the Carbodiimides compound concentrations is the aqueous solution of 0.001～1M, preferred concentration is 0.01～0.3M.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021124981A CN1179758C (en) | 2002-07-10 | 2002-07-10 | Preparation method of collagen/chitosan porous scaffold for tissue engineering |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021124981A CN1179758C (en) | 2002-07-10 | 2002-07-10 | Preparation method of collagen/chitosan porous scaffold for tissue engineering |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1394655A true CN1394655A (en) | 2003-02-05 |
| CN1179758C CN1179758C (en) | 2004-12-15 |
Family
ID=4742056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021124981A Expired - Fee Related CN1179758C (en) | 2002-07-10 | 2002-07-10 | Preparation method of collagen/chitosan porous scaffold for tissue engineering |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1179758C (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1321704C (en) * | 2004-03-24 | 2007-06-20 | 华东理工大学 | Method for fabricating activated artificial skin tissue in bilayer by using bioreactor |
| CN101884806A (en) * | 2010-07-09 | 2010-11-17 | 吴奕光 | Method for preparing cross-linked carboxymethyl chitin tissue engineering scaffold |
| CN101081314B (en) * | 2007-06-27 | 2010-12-08 | 浙江大学 | Method for preparation of collagen / chitose supporting stand of composite hydroxylapatite |
| CN102188747A (en) * | 2010-03-04 | 2011-09-21 | 浙江大学 | Compound tissue engineering scaffold containing PLGA (poly(lactic-co-glycolic acid) strengthening net, and preparation method and application thereof |
| CN101347637B (en) * | 2008-07-08 | 2011-12-07 | 深圳大学 | Method for preparing crosslinked carboxymethyl chitin tissue engineering stent |
| CN102327643A (en) * | 2011-08-23 | 2012-01-25 | 赵文 | Biological scaffold used for bone tissue regeneration |
| CN101357242B (en) * | 2007-05-31 | 2012-08-29 | 生立生物科技股份有限公司 | Structure for modulating intraocular pressure |
| CN102908666A (en) * | 2012-10-11 | 2013-02-06 | 天津市赛瑞生物技术有限公司 | Collagen scaffold material for cornea |
| CN101766837B (en) * | 2009-12-28 | 2013-03-27 | 中国人民解放军第二炮兵总医院 | Biomimetic porous microsphere tissue engineering scaffold and manufacturing method thereof |
| CN106913903A (en) * | 2017-04-20 | 2017-07-04 | 李丹荣 | A kind of preparation method for loading Bioglass skin regeneration material |
| CN107714285A (en) * | 2017-09-08 | 2018-02-23 | 李丹荣 | A kind of 3 D-printing combination negative-pressure irrigation integration dressing for skin and preparation method thereof |
| CN109821070A (en) * | 2019-02-22 | 2019-05-31 | 四川大学 | A kind of drying biological cardiac valves and preparation method thereof quickly flattened that soak |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1827525A2 (en) * | 2004-12-20 | 2007-09-05 | Carbgraft AB | Chitosan compositions |
-
2002
- 2002-07-10 CN CNB021124981A patent/CN1179758C/en not_active Expired - Fee Related
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1321704C (en) * | 2004-03-24 | 2007-06-20 | 华东理工大学 | Method for fabricating activated artificial skin tissue in bilayer by using bioreactor |
| CN101357242B (en) * | 2007-05-31 | 2012-08-29 | 生立生物科技股份有限公司 | Structure for modulating intraocular pressure |
| CN101081314B (en) * | 2007-06-27 | 2010-12-08 | 浙江大学 | Method for preparation of collagen / chitose supporting stand of composite hydroxylapatite |
| CN101347637B (en) * | 2008-07-08 | 2011-12-07 | 深圳大学 | Method for preparing crosslinked carboxymethyl chitin tissue engineering stent |
| CN101766837B (en) * | 2009-12-28 | 2013-03-27 | 中国人民解放军第二炮兵总医院 | Biomimetic porous microsphere tissue engineering scaffold and manufacturing method thereof |
| CN102188747A (en) * | 2010-03-04 | 2011-09-21 | 浙江大学 | Compound tissue engineering scaffold containing PLGA (poly(lactic-co-glycolic acid) strengthening net, and preparation method and application thereof |
| CN101884806B (en) * | 2010-07-09 | 2013-03-27 | 吴奕光 | Method for preparing cross-linked carboxymethyl chitin tissue engineering scaffold |
| CN101884806A (en) * | 2010-07-09 | 2010-11-17 | 吴奕光 | Method for preparing cross-linked carboxymethyl chitin tissue engineering scaffold |
| CN102327643A (en) * | 2011-08-23 | 2012-01-25 | 赵文 | Biological scaffold used for bone tissue regeneration |
| CN102327643B (en) * | 2011-08-23 | 2016-06-22 | 赵文 | A kind of biological support for osteanagenesis |
| CN102908666A (en) * | 2012-10-11 | 2013-02-06 | 天津市赛瑞生物技术有限公司 | Collagen scaffold material for cornea |
| CN106913903A (en) * | 2017-04-20 | 2017-07-04 | 李丹荣 | A kind of preparation method for loading Bioglass skin regeneration material |
| CN107714285A (en) * | 2017-09-08 | 2018-02-23 | 李丹荣 | A kind of 3 D-printing combination negative-pressure irrigation integration dressing for skin and preparation method thereof |
| CN107714285B (en) * | 2017-09-08 | 2021-07-06 | 李丹荣 | Three-dimensional printing and negative pressure flushing combined integrated skin dressing and preparation method thereof |
| CN109821070A (en) * | 2019-02-22 | 2019-05-31 | 四川大学 | A kind of drying biological cardiac valves and preparation method thereof quickly flattened that soak |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1179758C (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fornasari et al. | Natural-based biomaterials for peripheral nerve injury repair | |
| Torbet et al. | Orthogonal scaffold of magnetically aligned collagen lamellae for corneal stroma reconstruction | |
| EP2089073B1 (en) | Synthetic multi-layer corneal structures comprising collagen fibres | |
| CN1179758C (en) | Preparation method of collagen/chitosan porous scaffold for tissue engineering | |
| Kim et al. | Fabrication of duck’s feet collagen–silk hybrid biomaterial for tissue engineering | |
| US20130337227A1 (en) | Non-fibrogenesis collagen material and a manufacturing method thereof | |
| CN100553693C (en) | Asymmetric support of collagen-chitosan/fibrin glue and its production and application | |
| CN1919354A (en) | Artificial blood vessel silk fibroin and collagen blending pre-coagulation coating | |
| JP5453690B2 (en) | Collagen / chitosan composite fibrous porous body and method for producing the same | |
| KR100527623B1 (en) | Biodegradable polymer scaffold containing extracellular matrix used for artificial organs and method for preparing same | |
| Seifi et al. | A novel multifunctional chitosan-gelatin/carboxymethyl cellulose-alginate bilayer hydrogel containing human placenta extract for accelerating full-thickness wound healing | |
| Dong et al. | Electrospun nanofibrous membranes of recombinant human collagen type III promote cutaneous wound healing | |
| CN107349456B (en) | Preparation method of collagen sponge with pore size self-adaptive adjusting capacity and collagen sponge | |
| CN101264337A (en) | Preparation of collagen base biological medical material | |
| CN102038976A (en) | Regeneration material of dermis substitution for tissue engineering skin for loading rhGM-CSF and preparation method thereof | |
| CN111849864A (en) | Construction method and application of three-dimensional tumor model acellular derivative matrix scaffold | |
| Yang et al. | Effect of Dehydrothermal Treatment on the Structure and Properties of a Collagen-Based Heterogeneous Bilayer Membrane | |
| KR100304348B1 (en) | Reinforced collagen structure in the complex form of sponge and mesh | |
| CN116763990A (en) | Jellyfish cell removing material and preparation method and application thereof | |
| CN106166308B (en) | A kind of three-dimensional stephanoporate compound stent and preparation method thereof | |
| WO2003094985A1 (en) | Artificial extracellular matrix and process for producing the same | |
| CN111214703B (en) | iPS-derived myocardial cell composite patch and preparation and application thereof | |
| CN1363400A (en) | Internally depgradable composite support frame of liver and its preparing process | |
| He et al. | Silk Fibroin Scaffolds Facilitating the Repair of Rat Abdominal Wall Defect | |
| Qin et al. | Redesigned silk: a new macroporous biomaterial platform for antimicrobial dermal patches with unique exudate wicking ability |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041215 Termination date: 20200710 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |